Avanafil 31722-0442
Product NDC
31722-0442- Manufacturer
- Camber Pharmaceuticals, Inc.
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- June 14, 2024
- Listing Expires
- December 31, 2026
- Application
- ANDA209266
Need to source Avanafil? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Avanafil | 200 mg/1 |
Drug Class
Phosphodiesterase 5 Inhibitor [EPC]Phosphodiesterase 5 Inhibitor [EPC]Phosphodiesterase 5 Inhibitors [MoA]
Packaging Options(2)
100 TABLET in 1 BOTTLE (31722-442-01)
30 TABLET in 1 BOTTLE (31722-442-30)